27.7 C
Vientiane
Sunday, July 6, 2025
spot_img
Home Blog Page 778

AIM Vaccine’s mRNA RSV Vaccine Approved for U.S. Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment

AIM Vaccine Co., Ltd.
(a joint stock company incorporated in the People’s Republic of China with limited liability)
(Stock Code: 6660.HK)

HONG KONG, Feb. 27, 2025 /PRNewswire/ — The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical sector, PRC vaccine leader AIM Vaccine (06660.HK) announced on February 26 that its self-developed mRNA RSV (Respiratory Syncytial Virus) vaccine has recently received clinical trial approval from the U.S. Food and Drug Administration (FDA). The vaccine shows significantly higher humoral and cellular immunity compared to international marketed products. This product is expected to become a new growth driver for AIM Vaccine.

Analysts believe that the recent popularity of AI healthcare concepts in the Hong Kong stock market, benefiting from the recovery in market demand, performance growth, and rapid international expansion, is drawing more attention to the booming biopharmaceutical industry.

In line with the overall positive industry trend, AIM Vaccine has recently published several announcements, not only fully integrating DeepSeek’s large model to drive deep penetration of AI technology across the research, production, sales, and management sectors but also initiating a strategic upgrade to become an “AI + Smart Vaccine Enterprise.” Its ongoing mRNA RSV vaccine and mRNA shingles vaccine have both made significant progress, particularly the mRNA RSV vaccine obtaining U.S. clinical approval in a short time, demonstrating its innovation strength and instilling firm confidence in its performance growth and international expansion.

Fosun International Securities’ initial coverage report1 on AIM Vaccine notes that the company, leveraging its differentiated technological advantages and comprehensive product layout, not only displays significant leading potential in the domestic market but also has broad prospects for expansion in the international market, positioning itself to occupy an important place in the global vaccine market.

At this point in time, looking at the entire Hong Kong pharmaceutical sector, data tracked by Zheshang International shows that as of the week of February 23, the overall PE valuation level for the Hong Kong healthcare industry remains below the average since 2018, and there is still a significant gap compared to the peak levels.

Ping An Securities points out2, “Various policies supporting innovative drugs are being rolled out, and we believe the innovative drug sector has clear positive signals from a policy perspective.” Sinolink Securities anticipates that recent A-share and Hong Kong-listed pharmaceutical companies are about to enter their annual report window, expecting a sector-wide performance reversal post-reports, and the subsequent improvement in operational conditions and changes in performance rhythm are worth continuous tracking.

Focusing on AIM Vaccine as a leader in the vaccine industry, the Fosun International Securities research report suggests that AIM Vaccine’s valuation is lower than that of major Chinese competitors and global vaccine giants, indicating an overreaction by the market to its short-term losses and still low expectations for growth or profitability. The report predicts that from 2024 to 2027, AIM Vaccine’s revenue compound annual growth rate (CAGR) will reach 47%, with a projected breakeven in 2025 and net profit expected to exceed RMB 1.52 billion by 2027.

The approval of AIM Vaccine’s mRNA RSV vaccine for clinical trials in the U.S. is seen by analysts as further validation of the company’s “Innovation + Expansion” capabilities, potentially providing substantial support for the company’s performance growth and valuation recovery.

 

Hankyung.com introduces: CODIT Corp. Secures U.S. Patent for AI-Driven Legislative Intelligence Technology

  • Newly Patented Technology Improves Policy Research and Compliance Monitoring
  • CODIT Enhances Legislative Intelligence Offerings with U.S. Patent Recognition

SEOUL, South Korea, Feb. 27, 2025 /PRNewswire/ — A news report from Hankyung.com:

CODIT Corp., a leading AI-powered legislation and policy monitoring service, has been awarded a U.S. patent for its groundbreaking method and system that provides customized legislative and policy intelligence services. This innovation redefines how global businesses and institutions engage with, analyze, and respond to complex regulatory landscapes.

The patented technology, titled “Method and Computer-Readable Medium for Providing Service Information Including Bill Customized to User” (U.S. Patent No. 12,229,809 B2), elevates legislative intelligence by leveraging AI-driven analytics, advanced search logic, and dynamic keyword mapping. Designed to streamline the monitoring of high-volume legislative environments, this system provides businesses with real-time policy insights, ensuring they stay ahead of regulatory changes with greater accuracy and efficiency.

By integrating natural language processing (NLP) algorithms with logic-based search functions, the system automates policy trend analysis, enhances compliance monitoring, and strengthens risk management capabilities. It intelligently maps higher-order keywords to specific company and industry data, delivering precise, business-relevant legal insights that improve policy interpretation and strategic decision-making.

Unlike traditional keyword-based legal research, CODIT’s system dynamically links company and industry information to relevant bills, regulations, news, reports, and policy updates. This ensures comprehensive, context-aware legal analysis while allowing users to refine searches using advanced logical operators (AND, OR, NOT)—providing businesses with highly targeted results that adapt to shifting regulatory requirements.

“This patent marks a major milestone for CODIT Corp. and reinforces our leadership in legislative intelligence,” said CEO Ji Eun Chung. “As regulatory landscapes become more complex, our AI-powered technology provides multinational corporations and policymakers with the tools they need to track policy shifts, mitigate risks, and proactively engage in legislative discussions.”

Already adopted by global corporations and government institutions, this patent-backed technology is transforming how organizations interact with legislative bodies. With regulatory frameworks evolving across industries, CODIT ensures businesses have unparalleled access to real-time legislative developments, strengthening their ability to make informed, strategic decisions.

For U.S. enterprises and government institutions, CODIT provides tailored, data-driven insights to navigate both domestic and international regulatory landscapes in Korea and Japan. The system delivers real-time updates and in-depth analysis across key industries, including healthcare, ESG, HSE (Health, Safety, and Environment), AI, and Big Tech—empowering organizations to proactively manage regulatory challenges and ensure compliance with evolving policies.

About CODIT

CODIT is an AI-powered legislation and policy monitoring service that provides real-time tracking of legislation, policy, and media developments, with plans to expand into additional markets. The company is recognized for its unique blend of cutting-edge technology, expert policy consultancy, and strategic advocacy support.

For more information, please visit https://thecodit.com/kr-en or follow CODIT on LinkedIn.

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow 

JENA, Germany and SHANGHAI, Feb. 27, 2025 /PRNewswire/ — ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for surgically treating nearsightedness, with or without astigmatism. The latest generation of femtosecond lasers from ZEISS enters the China market at a time when more than 10 million eyes have been treated with ZEISS SMILE and SMILE pro worldwide, reflecting the technology’s broad global momentum driven by strong adoption in Asia, Europe and the U.S.

ZEISS VISUMAX 800 with SMILE pro software
ZEISS VISUMAX 800 with SMILE pro software

“With the growing interest in laser vision correction in China, the market needs innovative technology that enhances surgical outcomes, safety and efficiency to benefit both surgeons and their patients. The availability of the ZEISS VISUMAX 800 with SMILE pro software further extends our commitment to ophthalmologists and helps to solidify the future of laser vision correction across China,” says Maximilian Foerst, Head of ZEISS Greater China.

“ZEISS further sets itself apart in the China market with the availability of the VISUMAX 800 with SMILE pro software from ZEISS, providing the latest digital technology to meet the evolving needs of refractive surgeons worldwide,” said Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. “This next-generation femtosecond laser system creates data-driven insights to help surgeons better manage treatment paths for patients while supporting each surgeon’s unique practice requirements for greater workflow efficiency and performance.”

The VISUMAX® 800 with SMILE® pro software from ZEISS enables faster treatment, creating the lenticule in less than 10 seconds thanks to a faster laser pulse repetition rate of 2 MHz.* Additionally, the shorter procedure time can reduce stress for surgeons and their patients. The ZEISS femtosecond laser also provides greater flexibility for the surgeon and patient, with a smaller footprint and compatibility with a variety of patient beds, adapting to the clinical environment to provide cutting-edge technology without compromise.

With the availability of the VISUMAX® 800 with SMILE® pro software from ZEISS in China, surgeons can utilize a number of workflow enhancements including: the CentraLign® centration aid, a computer-controlled function for easy centration; the OcuLign® cyclotorsion adjustment to help counter cyclotorsion that may occur; and VISULYZE user nomograms to help surgeons collect and analyze patient data, while also providing detailed nomograms and enabling more control during every surgery.

With these workflow enhancements along with greater flexibility and faster treatment, the VISUMAX® 800 with SMILE® pro software from ZEISS offers substantial market opportunities for surgeons in China. For more information about the VISUMAX® 800 with SMILE® pro software from ZEISS, visit https://zeiss.com/visumax800  

* Data on file, myopia with optical zone 6.5 mm.

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals’ content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.

Contact for investors
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.med@zeiss.com

Contact for the press
Frank Smith
Head of Global Communications Ophthalmology
Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: press.med@zeiss.com

www.zeiss.com/newsroom 

 

McCrae Hospitals and Orion Health expand Viet Nam footprint through key partnerships

AUCKLAND, New Zealand, Feb. 27, 2025 /PRNewswire/ — A signing ceremony with New Zealand Prime Minister Christopher Luxon and Franco-Vietnamese (FV) Hospital Group in Ho Chi Minh City, Viet Nam yesterday marked the first milestone in preparation for the launch of ambitious Kiwi health tech innovation firm McCrae Hospitals, as well as Orion Health’s ongoing commitment to the region.

From left to right: Orion Health CEO Brad Porter, New Zealand Prime Minister Christopher Luxon (back left), McCrae Hospitals CEO Niru Rajakumar, FV Hospital CEO Dr Jean-Marcel Guillon, and Vietnam Prime Minister Pham Minh Chinh (back right)
From left to right: Orion Health CEO Brad Porter, New Zealand Prime Minister Christopher Luxon (back left), McCrae Hospitals CEO Niru Rajakumar, FV Hospital CEO Dr Jean-Marcel Guillon, and Vietnam Prime Minister Pham Minh Chinh (back right)

McCrae Hospitals is a fully Kiwi owned spinoff from Orion Health, the global New Zealand health technology firm recently acquired by Healwell AI. Both companies were founded by Ian McCrae and have agreed to work closely into the future across South-East Asia, ensuring the very best in New Zealand made health technology is on offer for Vietnamese patients and clinicians.

McCrae Hospitals CEO Niru Rajakumar says “the partnership agreement between FV Hospital and McCrae Hospitals, which becomes the new owner of the Hospital Information Systems (HIS) technology developed in New Zealand by Orion Health, is the launchpad for the next generation of hospital systems in South-East Asia.”

The agreement builds on strong foundations in the region previously championed by Orion Health. The two leading Kiwi firms will continue to work closely, with an announcement in January that existing customer Franco-Vietnamese (FV) Hospital will expand on its HIS with a new Orion Health Patient Portal (Virtuoso) designed to enhance care for over 770,000 patients and support more than 1,000 clinicians.

Set to go live this year, the patient portal will seamlessly integrate with FV’s systems, building on the HIS by enabling patients to manage their own health digitally and empowering patients to take control of their health.

Dr Jean-Marcel Guillon, CEO from FV Hospital shared: “The Virtuoso Patient Portal will greatly improve patient care by streamlining check-in processes, reducing admission times, and allowing patients to focus on their health rather than administrative tasks. This collaboration is a milestone in our decade-long partnership. Together, we empower patients and clinicians, driving impactful healthcare changes across Viet Nam and Southeast Asia.”

Prime Minister Luxon said “I am hugely proud that New Zealand’s HealthTech sector has evolved into a robust industry, now valued at NZ$2.1 billion according to the recent TIN200 report. This significant Kiwi technology project brings together the leading health care organisations from both countries and reinforces New Zealand’s commitment to strong, productive relationships in Viet Nam and South-East Asia and is aligned with our collaborative approaches to improving accessibility to equitable healthcare.”

“Improving both the patient and clinician experience, McCrae Hospital’s technology has built a strong reputation across South-East Asia, Australia and New Zealand for its ability to provide paperless patient journeys and streamline administrative operations from pre-admission through to post-discharge for patients.” says Rajakumar.

Rajakumar and the McCrae Hospitals customers will be supported by Asia Sales Director Timothy Kim, based in Viet Nam and previously of Orion Health, a cross-functional team in New Zealand, and a team of 35 based in Thailand form the heart of McCrae Hospitals research and development centre.

“We are proud of the strong reputation McCrae Hospitals technology inherits from its legacy with Orion Health. With customers in Viet Nam, Thailand and the Philippines, I’m excited to be leading McCrae Hospitals with an ambition to build on our reputation with hospitals throughout South-East Asia, Australia and New Zealand.”

Rajakumar says the opportunity to improve both the patient and clinician experience, saving their time and providing operator budget savings is something many hospitals are in search of.

About Orion Health  

Orion Health is a global healthcare technology company focused on reimagining healthcare for all. We are leading the change in digital health with health and care organizations to improve the well-being of every individual with our world-leading Unified Healthcare Platform. Made up of a Virtuoso digital front door, Amadeus digital care record, and Orchestral health intelligence platform – each underpinned by extensive health and social data sets, machine learning, and 30 years of innovation focused purely on improving global well-being. www.orionhealth.com 

China Liberal Education Holdings Limited Announces Share Consolidation

BEIJING, Feb. 27, 2025 /PRNewswire/ — China Liberal Education Holdings Limited (“China Liberal” or the “Company”) (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that the Company plans to effect a share consolidation of eighty (80) ordinary shares with par value of $0.225 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$18.0 (the “Share Consolidation”). As a result of the Share Consolidation, each eighty (80) pre-consolidation ordinary shares outstanding will automatically combine and convert into one issued and outstanding ordinary share without any action on the part of the shareholders.

The Share Consolidation will be effective on March 3, 2025. Beginning with the opening of trading on March 3, 2025, the Company’s ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol “CLEU” but under a new CUSIP number of G2161Y133. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Immediately following the Share Consolidation, the authorized share capital of the Company will be US$225,000,000 divided into 12,500,000 ordinary shares of US$18.0 par value each.

About China Liberal Education Holdings Limited

China Liberal is an educational services provider headquartered in Beijing, China. China Liberal provides a wide range of services, including technological consulting for Chinese universities to improve their campus information and data management systems, designed to enhance the teaching, operating, and management environment of the universities, thus establishing a “smart campus.” Additionally, China Liberal offers tailored job readiness training for graduating students. For more information, please visit the Company’s website at http://ir.chinaliberal.com/.

Forward-Looking Statements

This document contains forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s expectations and projections about future events, which the Company derives from the information currently available to the Company. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those using terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. When evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as required by law. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can provide no assurance that these expectations will prove to be accurate, and it cautions investors that actual results may differ materially from the anticipated results. Investors are encouraged to review the risk factors that may affect future results in the Company’s most recent annual report on Form 20-F for the year ended December 31, 2023 and in its other filings with the SEC.

Investor Relations Contact

China Liberal Education Holdings Limited
Email: ir@chinaliberal.com 

Ascent Investor Relations LLC
Tina Xiao
President
Phone: +1 646-932-7242
Email: investors@ascent-ir.com 

MTE HCMC 2025 – Connecting Vietnamese Developers and Industry Experts at Vietnam’s Premier Real Estate & Hospitality Conference

HO CHI MINH CITY, Vietnam, Feb. 27, 2025 /PRNewswire/ — Riding on the back of a very positive year for the hospitality market in Vietnam, with a rebound in tourism arrivals and strong growth in foreign travelers, Vietnam’s hospitality market is now poised for further improvements, new developments, investments, and exciting upgrades. The industry has fully recovered, and investments are expected to flow again into both city and coastal destinations, with growing interest from foreign investors.

In addition, 2024 marked a transitional period for Vietnam’s real estate industry. Key legislative changes have emerged as crucial factors shaping the industry’s future trajectory and building a foundation for improved market confidence. Increased interest in real estate, heightened investor sentiment, and a more stable economic environment are driving this positive momentum.

Demonstrating our long-standing commitment to industry growth, WeHub continues the Meet The Experts conference (MTE) – renowned as one of the largest conference series for real estate and hospitality professionals in Vietnam and the region. This highly anticipated event will take place in Ho Chi Minh City on March 18th, 2025, at the Landmark 81, Autograph Collection Hotel. MTE HCMC 2025 will bring together more than 50 international speakers and over 800 senior industry leaders, including representatives from real estate developers, hotel owners, architects, design consultants, project consultants, hotel operators, hotel general managers, and industry experts. The conference is ideal for foreign investors seeking to connect with local developers and hotel owners, as well as to be part of market updates and informative sessions.

The conference program will include presentations and panel discussions on various topics such as Vietnam and regional market updates, Vietnam Real Estate: Investment & Development, Risks & Opportunities, and the Vietnam Hospitality Landscape. Furthermore, speakers will discuss and share their perspectives on wellness, sustainability and its practical applications, the ultra-luxury segment, as well as the latest technologies shaping the future of hospitality and real estate, and many other prominent topics.

Mauro Gasparotti, Founder of WeHub, pointed out that “The MTE conference aims to strengthen connections among hospitality and real estate players, create collaboration opportunities, and provide valuable insights to developers, hotel owners, and industry partners, empowering them to seize opportunities and prepare for a new cycle in the real estate and hospitality markets.”

MTE HCMC 2025 - Event key visual
MTE HCMC 2025 – Event key visual

50+ Speakers | Keynote Speeches & Panel Discussions | Masterclasses | Technology Room | Developers Lounge | Exclusive Exhibition | HoSkar Night Networking | F&B Show

MTE HCMC 2025 content highlights:

  • Global & Local Hotel Outlook (Jesper Palmqvist – Regional Vice President, STR)
  • Earning Profit in Real Estate: Is It Finally Getting Easier in Vietnam? (Hieu Do, CFA – CEO, VinaLiving)
  • Asia’s Hospitality Landscape & Investment Opportunities (Mauro Gasparotti – Director, Savills Hotels & Founder, WeHub)
  • The Evolution Of Luxury Mixed-Use Resorts: A Case Study On Anantara Layan Phuket Resort, Branded Residences & Wellness (Yasin Munshi – Vice President Of Development – APAC, Minor Hotels)
  • Panel Discussion On Vietnam Hospitality Market: What Is Going On Out There?
  • Branded Residences & Ultra-Luxury: A Buyer’s Viewpoint (Otto Twist – Southeast Asia Residential Director, Savills Singapore)
  • Transforming resorts into All-Inclusive: Facilities & F&B, Capturing Revenues & Guest Experiences (Pep Vich – Msc Arch – Founding Partner, CMV Architects)
  • The Rise Of Wellness Real Estate In Vietnam: A Focus On Healthy Living (Khanh Nguyen – Head Of Vietnam Commercial, Gamuda Land)
  • Vietnam Residential Market: 2025 Trends & Buyer Preferences (Duong Bach – Country Manager, PropertyGuru Vietnam)
  • CEO Panel – Investment & Development: Navigating Regional Markets & Vietnam’s Prospects
  • And many other engaging topics

Beyond the main sessions as a conference, the MTE HCMC 2025 will also feature an experience room showcasing hotel technology, HoSkar Night networking session, F&B and various activities on the second day. These experiences will allow attendees to gain insights from practical examples, forge valuable connections, and explore potential collaborations. The organizers aim to create an immersive and engaging experience that will leave participants feeling inspired and empowered to their business in future.

Inquire to attend now: https://meettheexpertsevents.com/registration/ 

For more information about the event, please contact: Ms. Lisa via Host@wehubyou.com

Vision Asia Pacific is a registered company which owns WeHub and organizes many event series, including Meet The Experts conference (MTE) and HoSkar Night networking event.

NEXTCHEM (MAIRE) AWARDED A LICENSING CONTRACT BY TRANSITION INDUSTRIES FOR A 2.1 MILLION TONS PER YEAR ULTRA-LOW CARBON METHANOL PLANT IN MEXICO BASED ON ITS PROPRIETARY NX ADWINMETHANOL® ZERO TECHNOLOGY

  • NEXTCHEM’s proprietary NX AdWinMethanol® Zero offers an innovative process combining cutting-edge solutions to minimize carbon emissions, thanks to its autothermal reforming (ATR) technology 

  • The plant is poised to be one of the largest standalone ultra-low carbon chemical production facility in the world, with a total output in excess of 2.1 million ton/year

  • The whole package for the project is estimated to be around €250 million and includes also the basic engineering, proprietary and critical equipment supply, as well as assistance to commissioning, start-up and operation of the facility

MILAN, Feb. 27, 2025 /PRNewswire/ — MAIRE (MAIRE.MI) announces that NEXTCHEM’s subsidiary KT Tech has been awarded a licensing contract for the implementation of NEXTCHEM’s proprietary NX AdWinMethanol® Zero technology for Pacifico Mexinol, an ultra-low carbon methanol facility near Los Mochis, Sinaloa, on the Pacific coast of Mexico, with an output in excess of 2.1 million tons per year.  

Transition Industries LLC, a company based in Houston, Texas, is a developer of world-scale, ultra-low carbon emissions methanol and hydrogen facilities in North America. Transition Industries is jointly developing Pacifico Mexinol with the International Finance Corporation (IFC), a member of the World Bank Group.

When it initiates operation in 2028, Pacifico Mexinol is expected to be the largest single ultra-low carbon methanol facility in the world – producing approximately 350,000 metric tons of green methanol and 1.8 million metric tons of blue methanol annually from natural gas with carbon capture.

The value of the licensing award, which will be partly recognized upfront and partly at Final Investment Decision, is in the low tens of million euro, in line with transactions of this kind. The whole package is estimated to be about €250 million, also including the basic engineering, proprietary and critical equipment supply, as well as assistance to commissioning, start-up and operation of the facility.

The NX AdWinMethanol® Zero technology developed by GasConTec, NEXTCHEM’s subsidiary dedicated to low-carbon hydrogen and methanol solutions, integrates its proprietary Autothermal Reforming (ATR) process and methanol synthesis loop and proprietary CO2 capture technologies. This technology further minimizes carbon emissions to nearly zero by converting captured CO2 and green hydrogen into ultra-low-carbon methanol.

This innovative technological approach increases the sustainability of the methanol production process, reflecting Pacifico Mexinol’s commitment to addressing climate change.

Ultra-low carbon methanol can be used to facilitate the decarbonization of the hard to abate chemicals sectors.  The methanol produced by Pacifico Mexinol will facilitate the decarbonization of hundreds of downstream everyday products, including plastics, paints, car parts and construction materials.

Alessandro Bernini, Chief Executive Officer of MAIRE, commented: “We are honored to support this strategic project with NEXTCHEM’s cutting-edge technologies for ultra-low carbon energy vectors. This important achievement confirms our pivotal role in the energy transition and our ability to deliver advanced market-ready solutions that enable our clients to lead the way in producing clean chemical products.”

Rommel Gallo, Chief Executive Officer of Transition Industries, commented: “We are pleased to enter into this strategic relationship with NEXTCHEM and implement a world-class technology for the largest ultra-low carbon methanol facility in the world. We look forward to working together with NEXTCHEM to accelerate and lead the decarbonization of the global methanol and chemicals sectors.”

 

Moldova Digital Summit 2025: Accelerating Innovation & Investment in Eastern Europe

CHISINAU, Moldova, Feb. 27, 2025 /PRNewswire/ — The Moldova Digital Summit (MDS25) returns for its 14th edition from June 5th to 7th, 2025, building on the resounding success of last year’s event, which attracted over 3,000 attendees, facilitated 536 B2B meetings, and launched Moldova’s award-winning e-governance app, EVO. Under the patronage of Prime Minister Dorin Recean, MDS25 will convene global visionaries, industry leaders, policymakers, tech disruptors, and investors to explore the latest advancements and investment opportunities shaping Eastern Europe’s digital future.

Deputy Prime Minister, Minister of Economy, Dumitru Alaiba presenting at Moldova Digital Summit 2024
Deputy Prime Minister, Minister of Economy, Dumitru Alaiba presenting at Moldova Digital Summit 2024

Why Moldova? A Thriving Tech Hub

Moldova is rapidly becoming a powerhouse for digital innovation in Eastern Europe, with its IT sector gaining global recognition. Key factors contributing to this success include:

  • Moldova Innovation Technology Park: Europe’s first fully digital IT park, offering a streamlined operational model and a competitive 7% flat tax on revenue.
  • Impressive Growth: Consistent double-digit growth, attracting over 2,100 companies from over 40 countries, employing nearly 20,000 highly skilled professionals, and contributing 5% to the national GDP.
  • Government Support: Forward-thinking policies and initiatives foster innovation, investment, and talent development.

MDS25: Your Gateway to Opportunity

MDS25 offers a unique platform to connect with key players in Moldova’s thriving tech ecosystem and explore the vast potential of this rising digital hub.

Attendees can expect:

  • Global thought leadership: Engage with top-tier speakers.
  • Startup Alley: Discover Moldova’s most promising tech start-ups.
  • B2B & B2G matchmaking: Connect with investors, entrepreneurs, and government leaders.
  • Tech & Innovation Expo: Experience cutting-edge solutions.
  • Strategic Market Insights: Gain first-hand knowledge of Moldova’s IT sector.
  • Immersive Experience: Explore Moldova’s evolving tech landscape.

Secure your spot today! For a limited time, tickets are available at half price Get Your MDS25 Ticket Here

Register now at https://moldovadigitalsummit.md/ to receive event updates. Follow MDS25 on Facebook, Instagram and LinkedIn.

About Moldova Digital Summit

The MDS is Eastern Europe’s premier technology and innovation conference. Reaching its 14th edition, MDS continues to drive Moldova’s ambitions as a regional leader in technology, innovation, and entrepreneurship.

Organized by the Ministry of Economic Development and Digitalization, led by Minister Dumitru Alaiba, alongside key partners such as the National Association of ICT Companies (ATIC), Moldova Innovation Technology Park, the E-Governance Agency, Invest Moldova Agency, Startup Moldova, Tekwill, and the Technical University of Moldova, MDS2025 is set to position Moldova as a strategic destination for tech-driven growth and entrepreneurship.

Olga Ustunel-Cazacu
MDS25 Project Manager
olgaustunel@gmail.com